Accretion Nutraveda Ltd
₹0.00▲ +0.00 (+0.00%)
544694·NSE·Healthcare
Market Cap
198.20 Cr
PE Ratio
—
Volume
—
Day High - Low
—
52W High-Low
300.00 - 150.10
₹0.00▲ +0.00 (+0.00%)
Market Cap198.20 Cr
PE Ratio—
Volume—
Day High - Low—
52W High-Low300.00 - 150.10
Accretion Nutraveda Ltd (544694): company summary
Accretion Nutraveda Ltd (544694) is a micro-cap Healthcare company valued at ₹198 crore operating in Pharmaceuticals on the NSE and BSE.
Accretion Nutraveda Ltd (544694) is a micro-cap Healthcare company valued at ₹198 crore operating in Pharmaceuticals on the NSE and BSE.
- Financial performance
- Revenue has been growing strongly at 126.5% a year over three years; profit grew 162.6% a year, ahead of revenue — margins are expanding. Return on equity is 24.8%.
- Valuation multiples
- A price-to-earnings ratio is not meaningful here; the stock trades at 6.46 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
5.2/10
Weak
Fair Value
Sign in to see
ROE
24.80%
Strong
P/E
—
Debt / Equity
0.12
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed
Price performance
52W₹150.10
₹300.00
DocStoX take
Supported by growth (8.5) and quality (7.5), but held back by valuation (0.0). Growth looks strong at 8.5, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you. Scored on 4 of 5 measures.
DocStoX score
Medium confidence5.2
/10
Weak
Quality
Excellent
ROE 24.8%
Valuation
Expensive
P/B 6.5× vs 2.1× warranted by ROE
Growth
Strong
Revenue +126.5% 3Y CAGR
Risk
Elevated
D/E 0.12
Momentum
No data
No technical indicators
Scored on 4 of 5 measures — the rest have no data for this company.
At a glance
Market Cap
₹198 Cr
52W High / Low
₹300 / ₹150
Dividend Yield
0.00%
Promoter Holding
73.48%
EPS (TTM)
₹53.59
Book Value
₹42.41
Key highlights
- Profit compounding 163% a year
- Revenue compounding 127% a year
- Capital works hard — ROCE 57%
- Valuation is weak (0.0/10)
- Small ₹198 cr company — thinner liquidity
4 Positives2 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Accretion Nutraveda Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Accretion Nutraveda Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
SUN PHARMACEUTICAL IND LDIVI S LABORATORIES LTDTORRENT PHARMACEUTICALS LAPOLLO HOSPITALS ENTER. LZYDUS LIFESCIENCES LTDCIPLA LTDLAURUS LABS LIMITEDMAX HEALTHCARE INS LTDAUROBINDO PHARMA LTDDR. REDDY S LABORATORIESLUPIN LIMITEDMANKIND PHARMA LIMITED
Compare Accretion Nutraveda Ltd with peers
Related tools & concepts
Value Accretion Nutraveda Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing